Investor Relations

OPKO Health Announces Leadership Changes at BioReference Laboratories more »

OPKO'S GeneDx Announces Research Collaboration with Radboud University Medical Center more »

OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy more »

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 frost, phillip md et al May 31, 2017 185.6 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 30, 2017 189.5 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 26, 2017 186.3 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 25, 2017 189.5 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 23, 2017 193.2 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 22, 2017 184.8 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 19, 2017 186.9 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 18, 2017 191.8 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 17, 2017 189.5 KB View HTML View PDF View XLS  
4 hsiao, jane ph d May 12, 2017 156.1 KB View HTML View PDF View XLS  
4 rubin, steven d May 11, 2017 153.6 KB View HTML View PDF View XLS  
4 hsiao, jane ph d May 11, 2017 157.6 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 11, 2017 185.4 KB View HTML View PDF View XLS  
10-Q quarterly report May 10, 2017 424.8 KB View HTML View PDF View XLS View XBRL  
8-K current report May 9, 2017 198.9 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 9, 2017 191.7 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 8, 2017 186.7 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 5, 2017 188.6 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 4, 2017 186.0 KB View HTML View PDF View XLS  
4 frost, phillip md et al May 2, 2017 187.2 KB View HTML View PDF View XLS  
Showing 81-100 of 2171 Page: 1 2 3 4 5 6 7 8 9 ... 109  Previous 20 | Next 20

Email  Sign up for email alerts